Keywords: chiron, hsv-2, vaccine, improves, symptoms, recombinant, herpes
Chiron HSV-2 Vaccine Improves Symptoms
Article | 14 October 1996
- Chiron's recombinant Herpes simplex virus 2 vaccine can reduce the duration and severity of symptoms associated with the first post-immunization outbreak ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
